Previously, we had transfected CHD5 into several neuroblastoma lines (e.g., NLF, IMR5) [6], and although there was dramatic inhibition of growth, clonigenicity and tumorigenicity, we did not see any substantial morphological change or neuronal differentiation in these lines. The gene discussed is CHD5; the disease is neuroblastoma.